Literature DB >> 28374272

Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma.

Yuchen Wang1, B M Attar2,3, K Hinami4, H E Fuentes5, P Jaiswal5, H Zhang4, C S Simons-Linares5, A J Tafur6.   

Abstract

INTRODUCTION: Venous thromboembolism (VTE) is a common complication in cancer patients, and is associated with worse prognosis in such population. Hepatocellular carcinoma (HCC) poses high risk for VTE; however, data is scarce regarding the characteristics and consequences of VTE in HCC patients.
METHOD: We retrospectively reviewed the electronic medical records (EMR) of 270 patients diagnosed with HCC from 2000 to 2015 in Cook County Health and Hospitals System. We report the cumulative incidence of VTE in the present cohort, and identified through multivariate logistic regression the independent risk factors of the development of VTE. Overall prognosis of patients with and without VTE were presented and compared.
RESULTS: Sixteen cases (5.93%) of VTE were documented in the present study. In multivariate analysis, obesity, Child B cirrhosis, intra-hepatic lesions more than 3, and multi-organ extrahepatic metastasis were significantly associated with VTE development (p < 0.05). The presence of VTE was an independent risk factor for mortality in multivariate analysis (HR = 3.62, p = 0.021), together with male gender, Child C cirrhosis, and extrahepatic metastasis.
CONCLUSIONS: Obesity, Child B cirrhosis, more intra-hepatic lesions, and multi-organ extrahepatic metastasis are associated with cancer-associated VTE. VTE will adversely affect the prognosis of patients with HCC; therefore, primary thromboprophylaxis may be warranted in such population.

Entities:  

Keywords:  Hepatocellular carcinoma; Venous thromboembolism

Mesh:

Year:  2018        PMID: 28374272     DOI: 10.1007/s12029-017-9945-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  40 in total

Review 1.  Current strategy for staging and treatment: the BCLC update and future prospects.

Authors:  Alejandro Forner; María E Reig; Carlos Rodriguez de Lope; Jordi Bruix
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

2.  Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.

Authors:  A S Mansfield; A J Tafur; C E Wang; T V Kourelis; E M Wysokinska; P Yang
Journal:  J Thromb Haemost       Date:  2016-09-09       Impact factor: 5.824

3.  Trends in Hospitalization and Mortality of Venous Thromboembolism in Hospitalized Patients With Colon Cancer and Their Outcomes: US Perspective.

Authors:  Kalpit Devani; Nirav Patil; Carlos Roberto Simons-Linares; Nilay Patel; Palashkumar Jaiswal; Pranav Patel; Samir Patel; Chirag Savani; Kamlesh Sajnani; Mark Young; Chakradhar Reddy
Journal:  Clin Colorectal Cancer       Date:  2016-09-20       Impact factor: 4.481

4.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

Authors:  Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Joseph F Polak; Aaron R Folsom
Journal:  Arch Intern Med       Date:  2002-05-27

5.  Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.

Authors:  A S Mansfield; A J Tafur; D Vulih; G L Smith; P J Harris; S P Ivy
Journal:  Thromb Res       Date:  2015-10-20       Impact factor: 3.944

Review 6.  Venous thromboembolism in brain tumor patients.

Authors:  David J Cote; Timothy R Smith
Journal:  J Clin Neurosci       Date:  2015-11-17       Impact factor: 1.961

7.  Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases.

Authors:  Alex J Walker; Tim R Card; Joe West; Colin Crooks; Matthew J Grainge
Journal:  Eur J Cancer       Date:  2012-11-09       Impact factor: 9.162

8.  Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study.

Authors:  Mario Fusco; Pierluca Piselli; Saverio Virdone; Pietro Di Cicco; Paola Scognamiglio; Paolo De Paoli; Valerio Ciullo; Diana Verdirosi; Michele D'Orazio; Luigino Dal Maso; Enrico Girardi; Silvia Franceschi; Diego Serraino
Journal:  Infect Agent Cancer       Date:  2016-11-03       Impact factor: 2.965

Review 9.  Current concepts and management approaches in nonalcoholic fatty liver disease.

Authors:  Bashar M Attar; David H Van Thiel
Journal:  ScientificWorldJournal       Date:  2013-03-20

10.  Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.

Authors:  Alex J Walker; David R Baldwin; Tim R Card; Helen A Powell; Richard B Hubbard; Matthew J Grainge
Journal:  Br J Cancer       Date:  2016-06-02       Impact factor: 7.640

View more
  3 in total

1.  Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma.

Authors:  Yuchen Wang; Bashar M Attar; Harry E Fuentes; Palashkumar Jaiswal; Alfonso J Tafur
Journal:  J Gastrointest Oncol       Date:  2017-12

2.  More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.

Authors:  Marco Senzolo; Paolo Simioni; Alberto Zanetto; Elena Campello; Cristiana Bulato; Sabrina Gavasso; Graziella Saggiorato; Sarah Shalaby; Luca Spiezia; Umberto Cillo; Fabio Farinati; Francesco Paolo Russo; Patrizia Burra
Journal:  Hepatol Commun       Date:  2021-08-16

Review 3.  Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.

Authors:  Alberto Zanetto; Elena Campello; Luca Spiezia; Patrizia Burra; Paolo Simioni; Francesco Paolo Russo
Journal:  Cancers (Basel)       Date:  2018-11-16       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.